Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Roehrborn CG (2008) BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE. BJU Int 101(Suppl 3):17–21
2. Kupelian V, Wei JT, O’Leary MP et al (2006) Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med 27(166):2381–2387
3. Hays RD, Morales LS (2001) The RAND-36 measure of health-related quality of life. Ann Med 33:350–357
4. Gravas S (Chair) JNC, Gacci M, Gratzke C, Herrmann TRM, Mamoulakis C, Rieken M, Speakman MJ, K.A.O. Tikkinen Guidelines Associate: Karavitakis M, Kyriazis I, Malde S, Sakalis VI, Umbach R (2020) Management of Non-neurogenic Male LUTS: EAU Guidelines. EAU Guidelines 2020 ed
5. Gormley GJ, Stoner E, Bruskewitz RC et al (1992) The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. N Engl J Med 327:1185–1191
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献